Lv41
490 积分 2021-06-02 加入
Arvinas’s PROTACs pass first safety and PK analysis
2小时前
已完结
PROTACs: past, present and future
8天前
已完结
Protein Degradation in Focus
10天前
已完结
When CDK4/6i meets GPX4i: Stop dividing to die iron hard
1个月前
已完结
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer
1个月前
已完结
Discovery of Dual CDK6/PIM1 Inhibitors with a Novel Structure, High Potency, and Favorable Druggability for the Treatment of Acute Myeloid Leukemia
1个月前
已完结
Development of Degraders of Cyclin-Dependent Kinases 4 and 6 Based on Rational Drug Design
1个月前
已完结
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitors
1个月前
已完结
Discovery of a Novel Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2) and Cyclin-Dependent Kinase 4 (CDK4) Dual Inhibitor for the Treatment of Triple-Negative Breast Cancer
1个月前
已完结
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer
1个月前
已完结
皖公网安备34019202002308
